Genus PLC
LSE:GNS
Genus PLC
LSE:GNS
Price:
1 814 GBX
-0.55%
Market Closed
Updated:
Jun 7, 2024
Genus PLC
Selling, General & Administrative
|
Genus PLC
Selling, General & Administrative Peer Comparison
Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Genus PLC
LSE:GNS
|
Selling, General & Administrative
-£7.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Selling, General & Administrative
-$53.7m
|
CAGR 3-Years
-261%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Exscientia PLC
NASDAQ:EXAI
|
Selling, General & Administrative
-£41.2m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Selling, General & Administrative
-$54.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Selling, General & Administrative
-$62.3m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Selling, General & Administrative
-£144.5m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is Genus PLC's Selling, General & Administrative?
Selling, General & Administrative
-7.6m
GBP
-7.6m
GBP
Based on the financial report for Dec 31, 2023, Genus PLC's Selling, General & Administrative amounts to -7.6m GBP.
What is Genus PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-9%
-9%
Over the last year, the Selling, General & Administrative growth was -100%. The average annual Selling, General & Administrative growth rates for Genus PLC have been -1% over the past three years , -10% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
